Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-078638·REGENXBIO Inc.
Schedule 13G ownership disclosure
REGENXBIO Inc
Common Stock, par value $0.0001 per share · CUSIP: 75901B107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Redmile Group, LLC
Shares: 5,062,477.00 · Class: 9.9%
- Jeremy C. Green
Shares: 5,062,477.00 · Class: 9.9%
- Redmile Biopharma Investments III, L.P.
Shares: 3,733,796.00 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-078638
- Form type
- SCHEDULE 13G/A
- Filer
- REGENXBIO Inc.
- CIK
- CIK 1590877
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership